Abstract
Duvelisib (Copiktra((R))) is a dual inhibitor of phosphoinositide 3-kinases (PI3K delta and PI3K gamma). In 2018, duvelisib was first approved by the ......
小提示:本篇文献需要登录阅读全文,点击跳转登录